Mergers and Acquisitions

Unilife plans to fix its finances by selling the company or an asset, or entering a partnership

Unilife undecided on takeover plans; gives December 31 deadline

By Fiona BARRY

Unilife CEO Alan Shortall yesterday confirmed the drug delivery company is still “receiving interest from several parties under the strategic review process” and set a deadline of December 31 to announce any potential takeover.  The company received its...

The ex-Ben Venue plant shows no signs of reopening soon - and oncologists are reporting shortages

Still no plans to resume manufacturing at former Ben Venue plant

By Dan Rosenberg

The huge former Ben Venue injectables manufacturing plant in Ohio that became the center of controversy over drug shortages a few years ago remains off line, and the company that now owns the site reiterated this week that it has no plans to resume making...

Teva to Mylan: We will accomplish our 'strong and serious' proposal

UPDATE - Mylan demands a straightforward answer to whether Teva will make a legally binding exchange offer

Teva to Mylan: We will accomplish our 'strong and serious' takeover proposal

By Dan Stanton

Teva has refuted accusations of “meddling” with Mylan’s business in the latest chapter of what one analyst says is a far from friendly, if not hostile takeover attempt.

Teva accused of playing games with Mylan's business strategy

Mylan to Teva: 'Stop meddling in our affairs'

By Dan Stanton

Teva has been accused of "playing games" with Mylan by acquiring a 1.35% stake in the generics firm weeks after having a $40bn (EUR36bn) takeover bid snubbed.

Follow us


View more